comparemela.com

Latest Breaking News On - Fusion pharmaceuticals daily - Page 7 : comparemela.com

Fusion Pharmaceuticals (NASDAQ:FUSN) Sets New 52-Week High at $12.79

Fusion Pharmaceuticals (NASDAQ:FUSN) Sets New 52-Week High at $12.79
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Raymond-james
Renaissance-technologies
Fusion-pharmaceuticals-price-performance
Citadel-advisors
Hedge-funds-weigh-in-on-fusion-pharmaceuticals
Royal-bank
Fusion-pharmaceuticals-company-profile
Fusion-pharmaceuticals-inc
Nasdaq
Fusion-pharmaceuticals

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $12.79

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 1-Year High at $12.79
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Raymond-james
Fusion-pharmaceuticals-inc
Weiss-multi-strategy-advisers
Nasdaq
Fusion-pharmaceuticals-price-performance
Hedge-funds-weigh-in-on-fusion-pharmaceuticals
Fusion-pharmaceuticals
Cubist-systematic-strategies
Pier-capital
Royal-bank

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have been given a consensus recommendation of “Buy” by the eight analysts that are currently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]

United-states
Canada
William-blair
Raymond-james
Citadel-advisors
Royal-bank
Renaissance-technologies
Analyst-recommendations-for-fusion-pharmaceuticals
Nasdaq
Fusion-pharmaceuticals-inc
Fusion-pharmaceuticals
Institutional-trading-of-fusion-pharmaceuticals

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 52-Week High at $11.73

Fusion Pharmaceuticals (NASDAQ:FUSN) Hits New 52-Week High at $11.73
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Canada
William-blair
Royal-bank
News-ratings-for-fusion-pharmaceuticals-daily
Fusion-pharmaceuticals-stock-performance
Fusion-pharmaceuticals-inc
York-state-common-retirement-fund
Fusion-pharmaceuticals
Nasdaq
Millennium-management

Forefront Analytics LLC Has $88,000 Stock Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Forefront Analytics LLC grew its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 67.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 33,685 shares of the company’s stock after buying an additional 13,610 shares during the period. Forefront Analytics LLC’s holdings in […]

Canada
United-states
William-blair
Raymond-james
Forefront-analytics
Eagle-health-investments
Nasdaq
Royal-bank
Sphera-funds-management
Perceptive-advisors
Fusion-pharmaceuticals
News-ratings-for-fusion-pharmaceuticals-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.